← Back to headlines
Healthcare Hedge Fund Invests $24.5 Million in Immunovant Stock
A healthcare-focused hedge fund has recently acquired $24.5 million worth of Immunovant stock, prompting investors to consider the potential implications of this significant purchase.
15 Mar, 19:59 — 15 Mar, 19:59
Sources
Showing 1 of 1 sources
